Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2020 / Cilt: 54 - Sayı: 2

Clinical Characteristics of and Cancer Incidence in Children Evaluated for Lymphadenoapthy Referred to Pediatric Oncology Clinics

Sayfa
222–226
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This rate, which is too low for a reference center, suggested that the patients might be referred to the pediatric oncologyoutpatient clinic without a thorough evaluation in primary health care.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: In our study, we aimed to investigate the clinical characteristics and cancer frequency in patients referred to our pediatriconcology outpatient clinic for lymphadenopathy.Methods: The charts of patients admitted to our pediatric oncology outpatient clinics for lymphadenopathy between January 2014,and December 2016 were retrospectively reviewed in this study.
📊
Temel Bulgular & Veri:The frequency of malignancy was calculated.Results: One hundred thirty-four patients (34 girls) with a median age of six years (range four months-17 years) were includedin our study.
💡
Sonuç & Katkı:This rate, which is too low for a reference center, suggested that the patients might be referred to the pediatric oncologyoutpatient clinic without a thorough evaluation in primary health care.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: In our study, we aimed to investigate the clinical characteristics and cancer frequency in patients referred to our pediatriconcology outpatient clinic for lymphadenopathy.Methods: The charts of patients admitted to our pediatric oncology outpatient clinics for lymphadenopathy between January 2014,and December 2016 were retrospectively reviewed in this study. Age, gender, duration of complaints, previous therapies, systemicsigns and symptoms, lymph node characteristics and laboratory findings were recorded. The frequency of malignancy was calculated.Results: One hundred thirty-four patients (34 girls) with a median age of six years (range four months-17 years) were includedin our study. The majority of the patients (98%) had localized lymphadenopathy and the head and neck region was the mostcommon site of involvement (87%). The median long-axis diameter of lymph nodes ranged between 0.5 cm and 5 cm (median2 cm) by physical examination. Twenty-one patients (15.6%) had lymph node biopsy. Four patients had ruptured epidermal cyst,lymphangioma, pilomatricoma and ectopic thymus. Of the other biopsies, nine patients were diagnosed with reactive LAP, fourwith lymphadenitis, and four with Hodgkin’s disease. The lymphoma patients had lymph node size greater than 2.5 cm and theduration of lymphadenopathy was longer than four weeks. Three out of four patients had systemic clinical findings accompanyinglymph node enlargement.Conclusion: Three percent of the patients with lymphadenopathy who were referred for suspected malignancy received a cancerdiagnosis. This rate, which is too low for a reference center, suggested that the patients might be referred to the pediatric oncologyoutpatient clinic without a thorough evaluation in primary health care.

🔖

Bu Makaleye Atıf Yap

VURAL, S., GENÇ, D. B., ÇELİKBOYA, E. (2020). Clinical Characteristics of and Cancer Incidence in Children Evaluated for Lymphadenoapthy Referred to Pediatric Oncology Clinics. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 54 - Sayı: 2, 222–226. https://ajindex.com/articles/363660

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Kilburn LB, Malogolowkin MH, Quinn JJ, Siegel SS, Steuber CP. Clinical Assesment and differantial diagnosis of the child with suspected cancer. In: Pizzo PA, Poplac DG, David G, editors. Principles and Practice of Pediatric Oncology. 7th ed.Philadelphia: Lippincott Williams &Wilkins; 2015. p. 101–12
  2. Lanskowsky P. Lymphadenopathy and Diseases of the Spleen. In: Lanskowsky P, editor. Lanzkowsky's Manual of Pediatric Hematology and Oncology. 5th ed. NewYork: Elsevier; 2011. p. 461–71
  3. Niedzielska G, Kotowski M, Niedzielski A, Dybiec E, Wieczorek P. Cervical lymphadenopathy in children-incidence and diagnostic management. Int J Pediatr Otorhinolaryngol 2007;71:51–6
  4. Friedmann AM. Evaluation and management of lymphadenopathy in children. Pediatr Rev 2008;29:53–60
  5. Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. Am Fam Physician 2002;66:2103–10
  6. Herzog LW. Prevalence of lymphadenopathy of the head and neck in infants and children. Clin Pediatr (Phila) 1983;22:485–7
  7. Fragkandrea I, Nixon JA, Panagopoulou P. Signs and symptoms of childhood cancer: a guide for early recognition. Am Fam Physician 2013;88:185–92
  8. Locke R, Comfort R, Kubba H. When does an enlarged cervical lymph node in a child need excision? A systematic review. Int J Pediatr Otorhinolaryngol 2014;78:393–401
  9. Farndon S, Behjati S, Jonas N, Messahel B. How to use… lymph node biopsy in paediatrics. Arch Dis Child Educ Pract Ed 2017;102:244–8
  10. Meier JD, Grimmer JF. Evaluation and management of neck masses in children. Am Fam Physician 2014;89:353–8
  11. Ataş E, Kesik V, Fidancı MK, Kısmet E, KöseoğluV. Evaluation of children with lympadenopathy. Turk Pediatri Ars 2014;49:30–5
  12. Bozlak S, Varkal MA, Yildiz I, Toprak S, Karaman S, Erol OB, et al. Cervical lymphadenopathies in children: A prospective clinical cohort study. Int J Pediatr Otorhinolaryngol 2016;82:81–7
  13. Sarsu SB, Sahin K. A retrospective evaluation of lymphadenopathy in children in a single center's experience. J Pak Med Assoc 2016;66:654–7
  14. Karaman A, Karaman I, Cavuşoğlu YH, Erdoğan D. The ongoing problem with peripheral lymphadenopathies: which ones are malignant?. Pediatr Surg Int 2010;26:247–50
  15. Aykaç K, Özsürekci Y, Başaranoğlu ST, Öncel EK, Cengiz AB, Kara A, et al. Çocuklarda lenfadenopati nedenleri: Hacettepe Üniversitesi enfeksiyon hastalıkları deneyimi 2015-2016. Çocuk Sağlığı ve Hastalıkları Dergisi 2016;59:155–60
  16. Özkale Y, Özkale M, Sipah T. Peripheral Lymphadenopathy i